Contraceptives - Global Strategic Business Report

The global market for Contraceptives was valued at US$27.2 Billion in 2024 and is projected to reach US$39.3 Billion by 2030, growing at a CAGR of 6.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Contraceptives Market - Key Trends and Drivers Summarized

Contraceptives are medical products designed to prevent pregnancy by interfering with the normal process of ovulation, fertilization, or implantation. They come in various forms, including oral pills, condoms, intrauterine devices (IUDs), implants, injectables, patches, and emergency contraception pills. Each method offers different levels of effectiveness, durations of action, and suitability based on individual health profiles and preferences. The contraceptive market is driven by several key factors. One significant driver is the increasing awareness and education regarding sexual health and family planning. As governments and non-governmental organizations (NGOs) invest in public health campaigns and educational programs, more individuals are informed about the benefits and availability of contraceptives. This heightened awareness leads to higher adoption rates as people seek to take control of their reproductive health. Additionally, the growing support from various governments in the form of favorable policies and subsidies makes contraceptives more accessible and affordable, further boosting market growth.

The landscape of contraception is constantly evolving with the development of new methods and the extension of existing ones. There is a rising demand for long-acting reversible contraceptives (LARCs) such as IUDs and implants. These methods are becoming increasingly popular due to their high efficacy, convenience, and longer duration of action compared to short-term methods such as pills or condoms. Moreover, technological advancements are leading to the development of new and improved contraceptive options that offer better user experiences and fewer side effects. For instance, the advent of hormonal patches and vaginal rings provides more flexibility and ease of use, encouraging more individuals to consider these alternatives.

Contraceptive use is increasing worldwide, marking a positive shift in global reproductive health. Consumer preferences in the contraceptive market are also shifting towards products that offer additional health benefits beyond pregnancy prevention. For instance, some contraceptive pills are designed to alleviate menstrual-related issues such as heavy bleeding and severe cramps, making them more attractive to users. Furthermore, the rise of e-commerce platforms and telemedicine services is revolutionizing the way contraceptives are accessed and purchased. These digital channels provide greater privacy, convenience, and accessibility, particularly for individuals in remote or underserved areas. As a result, the contraceptive market is expanding to reach a broader audience, contributing to its sustained growth and development.

Report Scope

The report analyzes the Contraceptives market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments

Product Type (Drugs, Devices); Gender (Female, Male); End-Use (Household, Hospitals, Clinics).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Contraceptive Drugs segment, which is expected to reach US$26 Billion by 2030 with a CAGR of a 6.8%. The Contraceptive Devices segment is also set to grow at 5.5% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $7 Billion in 2024, and China, forecasted to grow at an impressive 9.8% CAGR to reach $9.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Agile Therapeutics, Inc., Allergan plc, Ansell Limited, Bayer AG, Church & Dwight Co., Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Contraceptives Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Contraceptives Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Contraceptives Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Some of the 92 major companies featured in this Contraceptives market report include:

• Agile Therapeutics, Inc.
• Allergan plc
• Ansell Limited
• Bayer AG
• Church & Dwight Co., Inc.
• CooperSurgical Inc.
• Fuji Latex Co. Ltd.
• Janssen Pharmaceuticals, Inc.
• Karex Berhad
• Mankind Pharma Ltd.
• Okamoto Industries, Inc.
• Pfizer Inc.
• Piramal Enterprises Ltd.
• Reckitt Benckiser Group Plc.
• Sagami Rubber Industries Co., Ltd.
• Teva Pharmaceutical Industries Ltd.
• Thai Nippon Rubber Industry Co., Ltd.